Myeloma Paper of the Day, July 8th, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Analysis of Canadian Myeloma Research Group Database finds tandem autologous transplantation (vs. 1 ASCT) does not benefit high-risk myeloma patients (overall and in subgroups) in the maintenance era on either PFS or OS.”
Source: Robert Orlowski/X
Authors: Christopher P Venner, Peter Duggan, Kevin Song, Donna Reece, Smriti Sharma, Jiandong Su, Victor H Jimenez-Zepeda, Arleigh McCurdy, Martha Louzada, Hira Mian, Michael Sebag, Darrell White, Julie Stakiw, Rami Kotb, Muhammad Aslam, Anthony Reiman, Engin Gul, Michael P Chu, Debra Bergstrom and Richard LeBlanc.
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
